Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Industri Jamu dan Farmasi Sido Muncul Tbk's quarterly Total Liabilities
increased
from Sep. 2025 (Rp330,149.00 Mil) to Dec. 2025 (Rp561,441.00 Mil) but then
declined
from Dec. 2025 (Rp561,441.00 Mil) to Mar. 2026 (Rp386,743.00 Mil).
PT Industri Jamu dan Farmasi Sido Muncul Tbk's annual Total Liabilities
declined
from Dec. 2023 (Rp504,765.00 Mil) to Dec. 2024 (Rp451,781.00 Mil) but then
increased
from Dec. 2024 (Rp451,781.00 Mil) to Dec. 2025 (Rp561,441.00 Mil).
PT Industri Jamu dan Farmasi Sido Muncul Tbk Total Liabilities Related Terms
PT Industri Jamu dan Farmasi Sido Muncul Tbk Total Liabilities Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Industri Jamu dan Farmasi Sido Muncul Tbk Total Liabilities Chart
PT Industri Jamu dan Farmasi Sido Muncul Tbk Annual Data
PT Industri Jamu dan Farmasi Sido Muncul Tbk Total Liabilities Calculation
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Total Liabilities of Rp386,743 Mil mean?
PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) has a Total Liabilities of Rp386,743 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for PT Industri Jamu dan Farmasi Sido Muncul Tbk and its competitors.
Is PT Industri Jamu dan Farmasi Sido Muncul Tbk's Total Liabilities too high?
PT Industri Jamu dan Farmasi Sido Muncul Tbk's current Total Liabilities is Rp386,743 Mil. Overall, PT Industri Jamu dan Farmasi Sido Muncul Tbk has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Industri Jamu dan Farmasi Sido Muncul Tbk's Total Liabilities compare to KHC and GIS?
PT Industri Jamu dan Farmasi Sido Muncul Tbk's Total Liabilities of Rp386,743 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Consumer Packaged Goods company?
A good Total Liabilities depends on the Consumer Packaged Goods industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for PT Industri Jamu dan Farmasi Sido Muncul Tbk and its competitors. PT Industri Jamu dan Farmasi Sido Muncul Tbk's current Total Liabilities is Rp386,743 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Industri Jamu dan Farmasi Sido Muncul Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp608.22, compared to a current price of Rp380.00 — trading 37.5% below its estimated fair value. The current Total Liabilities is Rp386,743 Mil. PT Industri Jamu dan Farmasi Sido Muncul Tbk's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO), the current Total Liabilities is Rp386,743 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Overvalued in 2026?
Based on GuruFocus' analysis, PT Industri Jamu dan Farmasi Sido Muncul Tbk stock appears to be undervalued.
The current stock price of Rp380.00 is trading 37.5% below its estimated GF Value™ of Rp608.22.
GuruFocus considers PT Industri Jamu dan Farmasi Sido Muncul Tbk to be Significantly Undervalued.
Key valuation signals for ISX:SIDO:
Total Liabilities: Rp386,743 Mil
GF Value™: Rp608.22 vs. price of Rp380.00 (37.5% below fair value)
No single metric tells the full story. See the ISX:SIDO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Industri Jamu dan Farmasi Sido Muncul Tbk Business Description
PT Industri Jamu dan Farmasi Sido Muncul Tbk is focused on the herbal medicine and herbal products industry, with its products categorized into three distinct segments: Herbal Medicine and Supplements, Food and Beverages, and Pharmaceuticals. Its flagship herbal products include Tolak Angin, available in variants such as Tolak Angin Cair, Tolak Angin Cair Anak, Tolak Angin Sugar Free, Tolak Angin Batuk, and Tolak Angin Flu. The Herbal Medicine segment provides herbal supplements, while its Food and Beverage segment sells packaged foods, soft drinks, and candy and confectionery products. The Pharmacy segment sells pharmaceutical products, including Anacetine Syrup, Inflasone, Berlosid, Licokalk, and Licodexon. The majority of revenue is derived from the Herbal Medicine & Supplement segment.
81GF Score
Get the complete analysis for ISX:SIDO
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SIDO has been successfully added to your 
